Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Thu Aug 31 00:00:00 GMT-05:00 2017
Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Me ...
PDF (230 KB)
Tue Aug 29 00:00:00 GMT-05:00 2017
Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic ...
PDF (179 KB)
Tue Aug 29 00:00:00 GMT-05:00 2017
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastati ...
PDF (178 KB)
Mon Aug 28 00:00:00 GMT-05:00 2017
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Select ...
PDF (256 KB)
Mon Aug 28 00:00:00 GMT-05:00 2017
Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo® (nivolu ...
PDF (389 KB)
Mon Aug 21 00:00:00 GMT-05:00 2017
Daiichi Sankyo, Inc. Announces Its Clinical Presentations at ESC Congress 2017
PDF (235 KB)
Tue Aug 01 00:00:00 GMT-05:00 2017
Daiichi Sankyo Announces Settlement Agreement on U.S. Products Liability Litigation
PDF (167 KB)
Tue Jul 18 00:00:00 GMT-05:00 2017
Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research Milestone in Bispecific ...
PDF (172 KB)
Tue Jul 11 00:00:00 GMT-05:00 2017
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaborat ...
PDF (174 KB)
Fri Jun 30 00:00:00 GMT-05:00 2017
Daiichi Sankyo Announces Top-line Results from Phase 3 Global Clinical Development Program Evaluati ...
PDF (96 KB)
Showing 21 - 30 of 42 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...